Neurodegeneration caused by proteins with an aberrant carboxyl-terminus

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 8, 2004, Pages 787-800

  Vidal, Ruben ^a   Delisle, Marie Bernadette ^b   Ghetti, Bernardino ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

ABri; ADan; Amyloid; Ferritin; Inclusion bodies; Neurodegeneration

Indexed keywords

AMYLOID PROTEIN; FERRITIN; POLYPEPTIDE;

ANIMAL CELL; BRI2 GENE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL INCLUSION; CHROMOSOME 13; CHROMOSOME 19; DEMENTIA; EXTRACELLULAR SPACE; GENE; GENE LOCATION; GENETIC DISORDER; HUMAN; HUMAN CELL; MOLECULAR GENETICS; MOLECULAR RECOGNITION; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; REVIEW;

EID: 3843069669     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.8.787     Document Type: Review

References (91)

1. Carrell RW, Lomas DA. Conformational disease. Lancet 1997;350:134-38
2. Fink AL. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 1998;3:R9-23
3. Walker LC, LeVine H. The cerebral proteopathies: Neurodegenerative disorders of protein conformation and assembly. Mol Neurobiol 2000;21:83-95
4. Dobson CM. Protein folding and misfolding. Nature 2003;426:884-90
5. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003;4:49-60
6. Crowther DC. Familial Conformational diseases and dementias. Hum Mutat 2002;20:1-14
7. Ingelsson M, Hyman BT. Disordered proteins in dementia. Ann Med 2002;34:259-71
8. Vidal R, Ghiso J, Frangione B. New familial forms of cerebral amyloid and dementia. Mol Psychiatry 2000;5:575-76
9. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-54
10. Vidal R, Ghetti B, Takao M, et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol 2004;63:363-80
11. Worster-Drought C, Hill TR, McMenemey WH. Familial presenile dementia with spastic paralysis. J Neurol Psychopathol 1933;14:27-34
12. Worster-Drought C, Greenfield JG, McMenemey WH. A form of familial presenile dementia with spastic paralysis (including the pathological examination of a case). Brain 1940;63:237-54
13. Worster-Drought C, Greenfield JG, McMenemey WH. A form of familial presenile dementia with spastic paralysis. Brain 1944;67:38-43
14. Plant GT, Revesz T, Barnard RO, Harding AE, Gautier-Smith PC. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain 1990;113:721-47
15. Mead S, James-Galton M, Revesz T, et al. Familial British dementia with amyloid angiopathy. Early clinical, neuropsychological and imaging findings. Brain 2000;123:975-91
16. Revesz T, Holton JL, Doshi B, Anderton BH, Scaravilli F, Plant GT. Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation. Acta Neuropathol (Berl) 1999;97:170-76
17. Holton JL, Ghiso J, Lashley T, et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 2001;158:515-26
18. Crook R, Verkkoniemi A, PerezTur J, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med 1998;4:452-55
19. Strömgren E, Dalby A, Dalby MA, Ranheim B. Cataract, deafness, cerebellar ataxia, psychosis and dementia: A new syndrome. Acta Neurol Scand 1970;46(Suppl 43):261-62
20. Strömgren E. Heredopathia ophthalmo-oto-encephalica. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Amsterdam: North-Holland Publishing Company, 1981;42:150-52
21. Plant GT, Esiri MM. Familial cerebral amyloid angiopathies. In: Esiri MM, Morris JH, eds. The neuropathology of dementia. Cambridge: University Press, 1977:260-76
22. Holton JL, Lashley T, Ghiso J, et al. Familial Danish dementia: A novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 2002;61:254-67
23. Bek T. Ocular changes in heredo-oto-ophthalmo-encephalopathy. Br J Ophthalmol 2000;84:1298-302
24. Vidal R, Revesz T, Rostagno A, et al. A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 2000;97:4920-25
25. Levy E, Sastre M, Kumar A, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol 2001;60:94-104
26. Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999;399:776-81
27. Deleersnijder W, Hong G, Cortvrindt R, et al. Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. Molecular cloning and characterization of a gene belonging to a novel multigene family of integral membrane proteins. J Biol Chem 1996;271:19475-82
28. Kirchner J, Bevan MJ. ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes. J Exp Med 1999;190:217-28
29. Kim SH, Wang R, Gordon DJ, et al. Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci 1999;2:984-88
30. 3, a member of the BRI gene family. Gene 2001;266:95-102
31. Pittois K, Wauters J, Bossuyt P, Deleersnijder W, Merregaert J. Genomic organization and chromosomal localization of the Itm2a gene. Mamm Genome 1999;10:54-56
32. Pittois K, Deleersnijder W, Merregaert J. cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. Gene 1998;217:141-49
33. Tuckermann JP, Pittois K, Partridge NC, Merregaert J, Angel P. Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation: Sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse. J Bone Miner Res 2000;15:1257-65
34. Mao M, Fu G, Wu JS, et al. Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning. Proc Natl Acad Sci USA 1998;95:8175-80
35. Shridhar V, Sen A, Chien J, et al. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 2002;62:262-70
36. Pickford F, Onstead L, Camacho-Prihar C, Hardy J, McGowan E. Expression of mBRI2 in mice. Neurosci Lett 2003;338:95-98
37. Schwab C, Hosokawa M, Akiyama H, McGeer PL. Familial British dementia: Colocalization of furin and ABri amyloid. Acta Neuropathol (Berl) 2003;106:278-84
38. Akiyama H, Kondo H, Arai T, et al. Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol (Berl) 2004;107:53-58
39. Choi SI, Vidal R, Frangione B, Levy E. Axonal transport of British and Danish amyloid peptides via secretory vesicles. FASEB J 2004;18:373-75
40. Latil A, Chene L, Mangin P, Fournier G, Berthon P, Cussenot O. Extensive analysis of the 13ql4 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Prostate 2003;57:39-50
41. Fleischer A, Ayllon V, Dumoutier L, Renauld JC, Rebollo A. Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2. Oncogene 2002;21:3181-89
42. Fleischer A, Rebollo A. Induction of p53-independent apoptosis by the BH3-only protein ITM2Bs. FEES Lett 2004;557:283-87
43. Rissoan MC, Duhen T, Bridon JM, et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002;100:3295-303
44. Sanchez-Pulido L, Devos D, Valencia A. BRICHOS: A conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci 2002;27:329-32
45. Kim SH, Creemers JW, Chu S, Thinakaran G, Sisodia SS. Proteolytic processing of familial British dementia-associated BRI variants: Evidence for enhanced intracellular accumulation of amyloidogenic peptides. J Biol Chem 2002;277:1872-77
46. Nakayama K. Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 1997;327:625-35
47. Zhou A, Webb G, Zhu X, Steiner DF. Proteolytic processing in the secretory pathway. J Biol Chem 1999;274:20745-48
48. Lewis PA, Piper S, Baker M, et al. Expression of BRI-amyloid beta peptide fusion proteins: A novel method for specific high-level expression of amyloid beta peptides. Biochim Biophys Acta 2001;1537:58-62
49. Ghiso JA, Holton J, Miravalle L, et al. Systemic amyloid deposits in familial British dementia. J Biol Chem 2001;276:43909-14
50. Sykes PA, Watson SJ, Temple JS, Bateman RC Jr. Evidence for tissue-specific forms of glutaminyl cyclase. FEBS Lett 1999;455:159-61
51. Saido TC, Yamao-Harigaya W, Iwatsubo T, Kawashima S. Amino-and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci Lett 1996;215:173-76
52. Iwatsubo T, Saido TC, Mann DM, Lee VM, Trojanowski JQ. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. Am J Pathol 1996;149:1823-30
53. Tekirian TL, Saido TC, Markesbery WR, et al. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J Neuropathol Exp Neurol 1998;57:76-94
54. He W, Barrow CJ. The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. Biochemistry 1999;38:10871-77
55. Tomidokoro Y, Fleire S, Rostagno A, et al. Co-existence of amyloid ADan and amyloid-β in familial Danish dementia. Neurobiol Aging 2002;23:S455
56. El-Agnaf OM, Sheridan JM, Sidera C, et al. Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia. Biochemistry 2001;40:3449-57
57. El-Agnaf OM, Nagala S, Patel BP, Austen BM. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J Mol Biol 2001;310:157-68
58. Mahadevan D, Chattopadhyay T, Palmer RA, O'Brien R, Saldanha JW. Predicted fold for the ABri amyloid subunit: A model for amyloidogenesis in familial British dementia. Protein Pept Letters 2001;8:171-78
59. Srinivasan R, Jones EM, Liu K, Ghiso J, Marchant RE, Zagorski MG. pH-dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. J Mol Biol 2003;333:1003-23
60. Gibson G, Gunasekera N, Lee M, et al. Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia. J Neurochem 2004;88:281-90
61. Walsh DM, Hartley DM, Kusumoto Y, et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 1999;274:25945-52
62. Rostagno A, Revesz T, Lashley T, et al. Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease. J Biol Chem 2002;277:49782-90
63. Chinnery PF, Curtis AR, Fey C, et al. Neuroferritinopathy in a French family with late onset dominant dystonia. J Med Genet 2003;40:69
64. Wills AJ, Sawle GV, Guilbert PR, Curtis AR. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry 2002;73:91-92
65. Delisle MB, Uro-Coste E, Rascol O, et al. A neurodegenerative disease with intranuclear deposits: Clinical and neuropathologic studies. J Neuropathol Exp Neurol 2001;60:514
66. Vidal R, Benson MD, Liepnieks JM, et al. A neurodegenerative disease with intranuclear protein deposits: Electron microscopic and biochemical studies. J Neuropathol Exp Neurol 2001;60:515
67. Harrison PM, Arosio P. The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203
68. McKusick, VA. FERRITIN HEAVY CHAIN 1; FTH1. http://www.ncbi.nlm.nih.gov/ entrez/dispomim.cgi?id=134770; 12/5/2001
69. McKusick, VA. FERRITIN LIGHT CHAIN; FTL. http://www.ncbi.nlm.nih.gov/ entrez/dispomim.cgi?id=134790; 10/21/2002
70. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996;93:8175-82
71. Rouault T, Klausner R. Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul 1997;35:1-19
72. Rouault TA, Klausner RD. Ironsulfur clusters as biosensors of oxidants and iron. Trends Biochem Sci 1996;21:174-77
73. Cairo G, Castrusini E, Minotti G, Bernelli-Zazzera A. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: A protective stratagem against oxidative injury. FASEB J 1996;10:1326-35
74. Orino K, Lehman L, Tsuji Y, et al. Ferritin and the response to oxidative stress. Biochem J 2001;357:241-47
75. Cazzola M, Skoda RC. Translational pathophysiology: A novel molecular mechanism of human disease. Blood 2000;95:3280-88
76. McKusick, VA. Hyperferritinemia-cataract syndrome. http://www.ncbi.nlm. nih.gov/entrezydispomim.cgi?id=600886; 10/21/2002
77. Kato J, Fujikawa K, Kanda M, et al. A mutation in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-97
78. LaVaute T, Smith S, Cooperman S, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001;27:209-14
79. Crompton DE, Chinnery PF, Fey C, et al. Neuroferritinopathy: A window on the role of iron in neurodegeneration. Blood Cells Mol Dis 2002;29:522-31
80. Granier T, Langlois d'Estaintot B, et al. Structural description of the active sites of mouse L-chain ferritin at 1.2 A resolution. J Biol Inorg Chem 2003;8:105-11
81. Jappelli R, Luzzago A, Tataseo P, Pernice I, Cesareni G. Loop mutations can cause a substantial conformational change in the carboxy terminus of the ferritin protein. J Mol Biol 1992;227:532-43
82. Jappelli R, Cesareni G. Cooperativity of mutational effects within a six amino acid residues substitution that induces a major conformational change in human H ferritin. Biochem Biophys Res Commun 1998;250:342-46
83. Kondo A, Deguchi J, Okada S. Intranuclear iron deposition in hepatocytes and renal tubular cells in mice treated with ferric nitrilotriacetate. Virchows Arch 1998;433:543-48
84. Smith AG, Carthew P, Francis JE, Edwards RE, Dinsdale D. Characterization and accumulation of ferritin in hepatocyte nuclei of mice with iron overload. Hepatology 1990;12:1399-405
85. Cai CX, Birk DE, Linsenmayer TF. Ferritin is a developmentally regulated nuclear protein of avian corneal epithelial cells. J Biol Chem 1997;272:12831-39
86. Thompson KJ, Fried MG, Ye Z, Boyer P, Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci 2002;115:2165-77
87. Cai CX, Linsenmayer TF. Nuclear translocation of ferritin in corneal epithelial cells. J Cell Sci 2001;114:2327-34
88. Ross CA. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 1997;19:1147-50
89. Ghiso J, Plant GT, Revesz T, Wisniewski T, Frangione B. Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein. J Neurol Sci 1995;129:74-75
90. Masters CL, Beyreuther K. The Worster-Drought syndrome and other syndromes of dementia with spastic paraparesis: The paradox of molecular pathology. J Neuropathol Exp Neurol 2001;60:317-19
91. Vidal R, Delisle MB, Rascol O, Ghetti B. Hereditary ferritinopathy. J Neurol Sci 2003;207:110-11